Home » Topics » BioWorld

BioWorld
RSS

COR RAISES $36.5 MILLION IN OFFERING

Oct. 31, 1991

CREATIVE BIO RAISES $14 MILLION IN STOCK SALE

Oct. 31, 1991

ANTICIPATED DATA PROPELS SYNERGEN STOCK

Oct. 31, 1991

GENENTECH SEEKS BUYER FOR GLC ASSOCIATES

Oct. 30, 1991

IMMUNE RESPONSE RAISES $44 MILLION

Oct. 30, 1991

MAGAININ FILES FOR 2 MILLION-SHARE IPO

Oct. 30, 1991

ANALYST UPGRADES IMMUNEX RATING

Oct. 30, 1991

CAL BIO RAISES $56.9 MILLION IN OFFERING

Oct. 30, 1991

ALLIANCE IMAGING AGENT ENTERS PHASE I

Oct. 30, 1991

FDA APPROVES BLOOD SUBSTITUTE TESTS

Oct. 30, 1991

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 20, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...